Modulation of response to estrogens in cultured human female bone cells by a non-calcemic Vitamin D analog: Changes in nuclear and membranal binding

Dalia Somjen*, Sara Katzburg, Orly Sharon, Alvin M. Kaye, Batya Gayer, Fortune Kohen, David Hendel, Gary H. Posner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Estradiol17β (E2) and the phytoestrogens genistein (G), and daidzein (D) increase creatine kinase (CK) specific activity in primary cell cultures of human female to a greater extent in cells from pre-menopausal than post-menopausal women. Pretreatment with the non-calcemic analog of Vitamin D, JK 1624 F2-2 (JKF), upregulated this estrogenic response at all ages. In contrast, biochainin A (BA) and quercertin (Qu) increased CK with no age dependence or modulation by JKF pretreatment. Both ERα and ERβ present in the cells were upregulated by pretreatment with JKF, as measured by Western blot analysis. Real time PCR showed no significant change in ERα mRNA but a marked decrease in ERβ mRNA in both age groups after JKF treatment. Cells from both age groups had surface binding sites for E 2, shown by assays using cell impermeable Europium labeled ovalbumin-E2 conjugate (Eu-Ov-E2). Binding of [ 3H]-E2 to intracellular E2 receptors (ERs) was similar in both age groups with differences in phytoestrogenic competition. JKF pretreatment increased nuclear but decreased membranal binding in both age groups. These results provide evidence for membranal, in addition to nuclear estrogen receptors which are differentially modulated by a Vitamin D analog.

Original languageEnglish
Pages (from-to)393-395
Number of pages3
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume89-90
DOIs
StatePublished - May 2004
Externally publishedYes

Keywords

  • "Non-hypercalcemic" Vitamin D analogs
  • Estrogen receptors α and β
  • Membranal binding
  • Phytoestrogens

Fingerprint

Dive into the research topics of 'Modulation of response to estrogens in cultured human female bone cells by a non-calcemic Vitamin D analog: Changes in nuclear and membranal binding'. Together they form a unique fingerprint.

Cite this